About
Provided by Foley & Lardner LLP
As the preeminent law firm for pharmaceutical and biotechnology firms, laboratories, and clinical research organizations, Foley’s life sciences team brings nearly 30 years of experience in providing effective, legal solutions at every stage of development. These include start-ups and research institutions to mature global enterprises. Our global life sciences team is composed of more than 200 corporate, health care, regulatory, and IP attorneys and patent professionals across the U.S. and in Mexico. Nearly 80 percent of our team have earned Ph.D.s in diverse scientific disciplines. With their deep industry knowledge and significant research and commercial experience in key industry areas, they have the ability to understand the unique and complex technologies our clients face today.
Our life sciences team represents start-up and established enterprise clients developing strategies in forward-looking and high-growth areas. These include CAR-T cell therapy, CRISPR gene editing, liquid biopsy for early cancer detection, personalized/precision medicine, network science for predictive modeling, AI/machine learning for diagnostics and big data issues, and IoT and blockchain for digital wearables and connected care devices. Foley brings its substantial expertise in health care, FDA regulatory and compliance, telemedicine and digital health, IP, and transactions to support our nationwide client base of device companies in these areas.